| Version |
2.5 |
| Creation Date |
2005-11-16 15:48:42 |
| Update Date |
2009-08-13 10:46:34 |
| Accession Number |
HMDB00643 |
| Secondary Accession Numbers |
Not Available |
| Common Name |
Coproporphyrin I |
| Description |
Coproporhyrin I is a porphyrin metabolite arising from heme synthesis. Porphyrins are pigments found in both animal and plant life.
Coproporphyrin I is a tetrapyrrole dead-end product from the spontaneous oxidation of the methylene bridges of coproporphynogen, arising from heme synthesis and secreted in feces and urine. Increased levels of coproporphyrins can indicate congenital erythropoietic porphyria or sideroblastic anaemia. Porphyria is a pathological state characterised by abnormalities of porphyrin metabolism and results in the excretion of large quantities of porphyrins in the urine and in extreme sensitivity to light. A large number of factors are capable of increasing porphyrin excretion, owing to different and multiple causes and etiologies: 1) the main site of the chronic hepatic porphyria disease process concentrates on the liver, 2) a functional and morphologic liver injury is almost regularly associated with this chronic porphyria, 3) the toxic form due to occupational and environmental exposure takes mainly a subclinical course.
Hepatic factors includes disturbance in coproporphyrinogen metabolism, which results from inhibition of coproporphyrinogen oxidase as well as from the rapid loss from, and diminished utilization of coproporphyrinogen in the hepatocytes, which may also explain why coproporphyrin, its autoxidation product, predominates physiologically in the urine; decreased biliary excretion of coproporphyrin leading to a compensatory urinary excretion, so that the coproporphyrin ring isomer ratio (1:III) becomes a sensitive index for impaired liver function and intrahepatic cholestasis; and disturbed activity of hepatic uroporphyrinogen decarboxylase. In itself, secondary coproporphyrinuria is not associated with porphyria symptoms of a hepatologic-gastroenterologic, neurologic, or dermatologic order, even though coproporphyrinuria can occur with such symptoms. (PMID: 3327428) |
| Synonyms |
- 3,8,13,18-Tetramethyl-21H,23H-porphine-2,7,12,17-tetrapropionate
- 3,8,13,18-Tetramethyl-21H,23H-porphine-2,7,12,17-tetrapropionic acid
- 3,8,13,18-tetramethyl-2,7,12,17-Porphinetetrapropionate
- 3,8,13,18-tetramethyl-2,7,12,17-Porphinetetrapropionic acid
|
| Chemical IUPAC Name |
3,8,13,18-tetramethyl-21H,23H-Porphine-2,7,12,17-tetrapropanoic acid |
| Chemical Formula |
C36H38N4O8 |
| Chemical Structure |
 |
| Chemical Taxonomy |
| Kingdom |
|
| Super Class |
|
| Class |
|
| Sub Class |
|
| Family |
|
| Species |
- carboxylic acid
- aromatic compound
- heterocyclic compound
|
| Biofunction |
| — |
| Application |
| — |
| Source |
|
|
| Average Molecular Weight |
654.709 |
| Monoisotopic Molecular Weight |
654.268982 |
| Isomeric SMILES |
CC1=C(CCC(O)=O)/C2=C/C3=N/C(=CC4=C(C)C(CCC(O)=O)=C(N4)C=C4/N=C(/C=C1N2)C(CCC(O)=O)=C/4C)/C(CCC(O)=O)=C3C |
| Canonical SMILES |
CC1=C(CCC(O)=O)C2=CC3=NC(=CC4=C(C)C(CCC(O)=O)=C(N4)C=C4N=C(C=C1N2)C(CCC(O)=O)=C4C)C(CCC(O)=O)=C3C |
| KEGG Compound ID |
C02667  |
| BioCyc ID |
Not Available |
| BiGG ID |
Not Available |
| Wikipedia Link |
Not Available |
| NuGOwiki Link |
HMDB00643  |
| Metagene Link |
HMDB00643  |
| METLIN ID |
5616  |
| PubChem Compound |
68271  |
| PubChem Substance |
210397  |
| ChEBI ID |
28421  |
| CAS Registry Number |
531-14-6 |
| InChI Identifier |
InChI=1/C36H38N4O8/c1-17-21(5-9-33(41)42)29-14-26-19(3)23(7-11-35(45)46)31(39-26)16-28-20(4)24(8-12-36(47)48)32(40-28)15-27-18(2)22(6-10-34(43)44)30(38-27)13-25(17)37-29/h13-16,37,40H,5-12H2,1-4H3,(H,41,42)(H,43,44)(H,45,46)(H,47,48)/b25-13-,26-14-,27-15-,28-16-,29-14-,30-13-,31-16-,32-15- |
| Synthesis Reference |
Schonheyder, Fritz. The formation of coproporphyrin I and hemoglobin during embryonic life. Journal of Biological Chemistry (1938), 123 491-7. |
| Melting Point (Experimental) |
Not Available |
| Experimental Water Solubility |
Not Available
Source: PhysProp
|
| Predicted Water Solubility |
0.0309 mg/mL [Predicted by ALOGPS]
Calculated using ALOGPS
|
| Physiological Charge |
-4 |
| State |
Solid |
| Experimental LogP/Hydrophobicity |
Not Available
Source: PhysProp
|
| Predicted LogP/Hydrophobicity |
2.53 [Predicted by ALOGPS]; 0.7 [Predicted by PubChem via XLOGP]
Calculated using ALOGPS
|
| Material Safety Data Sheet (MSDS) |
|
| MOL File |
Show |
| SDF File |
Show |
| PDB File |
Show |
| 2D Structure |
|
| 3D Structure |
|
| Experimental PDB ID |
1R3Q  |
| Experimental PDB File |
Show |
| Experimental PDB Structure |
|
| Experimental 1H NMR Spectrum |
Download Spectrum Download FID (Bruker) Show Experimental Conditions  |
| Experimental 13C NMR Spectrum |
Not Available |
| Experimental 13C HSQC Spectrum |
Download Spectrum Download FID (Bruker) Show Experimental Conditions  |
| Predicted 1H NMR Spectrum |
Show Image Show Peaklist
|
| Predicted 13C NMR Spectrum |
Show Image Show Peaklist
|
| Mass Spectrum |
|
| Simplified TOCSY Spectrum |
Not Available |
| BMRB Spectrum |
Not Available |
| Cellular Location |
|
| Biofluid Location |
|
| Tissue Location |
| Tissue |
References |
| Liver |
— |
|
| Concentrations (Normal) |
| Biofluid |
Blood |
| Value |
0.005 (0.000 - 0.010) uM |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Patient information |
Normal |
| Comments |
Not Available |
| References |
- Hindmarsh JT, Oliveras L, Greenway DC: Biochemical differentiation of the porphyrias. Clin Biochem. 1999 Nov;32(8):609-19. [PubMed
]
|
| Biofluid |
Blood |
| Value |
0.0073 +/- 0.0035 uM |
| Age |
Newborn:0-30 days old |
| Sex |
Both |
| Patient information |
Normal |
| Comments |
Not Available |
| References |
- Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.
|
| Biofluid |
Blood |
| Value |
0.012 +/- 0.005 uM |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Patient information |
Normal |
| Comments |
Not Available |
| References |
- Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.
|
| Biofluid |
Urine |
| Value |
0.0036 +/- 0.0015 umol/mmol creatinine |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Patient information |
Normal |
| Comments |
Not Available |
| References |
- Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by Cornelius Lentner.
- West Cadwell, N.J. : Medical education Div., Ciba-Geigy Corp.
- Basel, Switzerland c1981-1992.
|
| Biofluid |
Urine |
| Value |
0.0021 +/- 0.001 umol/mmol creatinine |
| Age |
Adult:>18 yrs old |
| Sex |
Female |
| Patient information |
Normal |
| Comments |
Not Available |
| References |
- Li J, Cai Z: Stacking and separation of urinary porphyrins in capillary electrophoresis: optimization of concentration efficiency and resolution. Talanta. 2008 Oct 19;77(1):331-9. Epub 2008 Jul 1. [PubMed
]
|
| Biofluid |
Urine |
| Value |
0.0020 +/- 0.0011 umol/mmol creatinine |
| Age |
Adult:>18 yrs old |
| Sex |
Male |
| Patient information |
Normal |
| Comments |
Not Available |
| References |
- Li J, Cai Z: Stacking and separation of urinary porphyrins in capillary electrophoresis: optimization of concentration efficiency and resolution. Talanta. 2008 Oct 19;77(1):331-9. Epub 2008 Jul 1. [PubMed
]
|
| Biofluid |
Urine |
| Value |
0.0049 +/- 0.00019 umol/mmol creatinine |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Patient information |
Normal |
| Comments |
Not Available |
| References |
- Zuijderhoudt FM, Koehorst SG, Kluitenberg WE, Dorresteijn-de Bok J: On accuracy and precision of a HPLC method for measurement of urine porphyrin concentrations. Clin Chem Lab Med. 2000 Mar;38(3):227-30. [PubMed
]
|
| Biofluid |
Urine |
| Value |
0.0098 (0.0053-0.017) umol/mmol creatinine |
| Age |
Newborn:0-30 days old |
| Sex |
Both |
| Patient information |
Normal |
| Comments |
Not Available |
| References |
- Ozalla D, Herrero C, Ribas-Fito N, To-Figueras J, Toll A, Sala M, Grimalt J, Basagana X, Lecha M, Sunyer J: Evaluation of urinary porphyrin excretion in neonates born to mothers exposed to airborne hexachlorobenzene. Environ Health Perspect. 2002 Feb;110(2):205-9. [PubMed
]
|
|
| Concentrations (Abnormal) |
| Biofluid |
Blood |
| Value |
0.008 (0.000 - 0.016) uM |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Condition |
Porphyria |
| Comments |
Porphyria cutanea tarda |
| References |
- Hindmarsh JT, Oliveras L, Greenway DC: Biochemical differentiation of the porphyrias. Clin Biochem. 1999 Nov;32(8):609-19. [PubMed
]
|
| Biofluid |
Blood |
| Value |
0.0850 (0.0008 - 0.1700) uM |
| Age |
Adult:>18 yrs old |
| Sex |
Male |
| Condition |
Porphyria |
| Comments |
Not Available |
| References |
- Hindmarsh JT, Oliveras L, Greenway DC: Biochemical differentiation of the porphyrias. Clin Biochem. 1999 Nov;32(8):609-19. [PubMed
]
|
| Biofluid |
Urine |
| Value |
0.0042 +/- 0.00019 umol/mmol creatinine |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Condition |
Liver disease |
| Comments |
Not Available |
| References |
- Zuijderhoudt FM, Koehorst SG, Kluitenberg WE, Dorresteijn-de Bok J: On accuracy and precision of a HPLC method for measurement of urine porphyrin concentrations. Clin Chem Lab Med. 2000 Mar;38(3):227-30. [PubMed
]
|
| Biofluid |
Urine |
| Value |
0.002 +/- 0.00019 umol/mmol creatinine |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Comments |
Not Available |
| References |
- Zuijderhoudt FM, Koehorst SG, Kluitenberg WE, Dorresteijn-de Bok J: On accuracy and precision of a HPLC method for measurement of urine porphyrin concentrations. Clin Chem Lab Med. 2000 Mar;38(3):227-30. [PubMed
]
|
| Biofluid |
Urine |
| Value |
0.014 +/- 0.00013 umol/mmol creatinine |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Comments |
Not Available |
| References |
- Zuijderhoudt FM, Koehorst SG, Kluitenberg WE, Dorresteijn-de Bok J: On accuracy and precision of a HPLC method for measurement of urine porphyrin concentrations. Clin Chem Lab Med. 2000 Mar;38(3):227-30. [PubMed
]
|
| Biofluid |
Urine |
| Value |
0.0019 +/- 0.00085 umol/mmol creatinine |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Comments |
Not Available |
| References |
- Zuijderhoudt FM, Koehorst SG, Kluitenberg WE, Dorresteijn-de Bok J: On accuracy and precision of a HPLC method for measurement of urine porphyrin concentrations. Clin Chem Lab Med. 2000 Mar;38(3):227-30. [PubMed
]
|
| Biofluid |
Urine |
| Value |
0.0035 +/- 0.00013 umol/mmol creatinine |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Comments |
Not Available |
| References |
- Zuijderhoudt FM, Koehorst SG, Kluitenberg WE, Dorresteijn-de Bok J: On accuracy and precision of a HPLC method for measurement of urine porphyrin concentrations. Clin Chem Lab Med. 2000 Mar;38(3):227-30. [PubMed
]
|
| Biofluid |
Urine |
| Value |
0.015 (0.0067-0.021) umol/mmol creatinine |
| Age |
N/A |
| Sex |
Both |
| Comments |
Not Available |
| References |
- Ozalla D, Herrero C, Ribas-Fito N, To-Figueras J, Toll A, Sala M, Grimalt J, Basagana X, Lecha M, Sunyer J: Evaluation of urinary porphyrin excretion in neonates born to mothers exposed to airborne hexachlorobenzene. Environ Health Perspect. 2002 Feb;110(2):205-9. [PubMed
]
|
|
| Associated Disorders |
| Condition |
References |
| Liver disease |
- Zuijderhoudt FM, Koehorst SG, Kluitenberg WE, Dorresteijn-de Bok J: On accuracy and precision of a HPLC method for measurement of urine porphyrin concentrations. Clin Chem Lab Med. 2000 Mar;38(3):227-30. [PubMed
]
|
| Porphyria |
- Hindmarsh JT, Oliveras L, Greenway DC: Biochemical differentiation of the porphyrias. Clin Biochem. 1999 Nov;32(8):609-19. [PubMed
]
|
|
| OMIM ID |
Not Available |
| Pathways |
|
| General References |
Not Available |